About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Anxiety Clinical Trials in Philadelphia | 38 Studies

Clinical Trials AnxietyPhiladelphia

Anxiety Clinical Trials in Philadelphia

Find 38 clinical trials for anxiety near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Anxiety trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 38 trials

CompletedEvaluate the Safety of GABITRIL in Adults With Generalized Anxiety DisorderTo assess the long-term safety and tolerability of tiagabine treatment in patients with generalized anxiety disorder (GAD).NCT00233675·Mesa, Arizona and 27 others CompletedProof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325The purpose of this research study is to determine whether AstraZeneca's drug AZD7325 is safe and effective in the treatment of generalized anxiety disorder.NCT00807937·Mesa, Arizona and 50 others

Anxiety Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedA Problem Solving Intervention for Hospice CaregiversHospice care is conceptualized as quality compassionate care for people facing a life-limiting illness, with services that cover clinical care, pain management, and emotional and…NCT03712410·Philadelphia, Pennsylvania

TerminatedA 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)This is a 10-week trial that evaluates the efficacy and safety of PD 0332334 in subjects, ages from 18 to 65, with generalized anxiety disorder.NCT00658008·Litchfield Park, Arizona and 51 others

TerminatedA 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)This study will assess the long-term safety and tolerability of 350 to 600 mg/day of PD 0332334 administered in split dose (twice daily) in subjects with Generalized Anxiety…NCT00735267·Birmingham, Alabama and 92 others

CompletedA Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety DisorderThe purpose of the study is to assess the safety and effectiveness of the experimental drug, a benzodiazepine drug, in long-term use and the effects on quality of life, social and…NCT00106860·Bradenton, Florida and 12 others

CompletedA 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety DisorderThe purpose of this study is to evaluate the safety and efficacy of an investigational anti-anxiety medication relative to placebo in patients with generalized anxiety disorder…NCT00236015·Mesa, Arizona and 53 others

CompletedP3b Short-term Study of CTN in Patients With ADHD and Comorbid AnxietyPrimary: To evaluate the efficacy of CTN in adults ages with ADHD and comorbid anxiety (AISRS) Key Secondary: To assess the efficacy of CTN in adults ages with ADHD and comorbid…NCT06973577·Dothan, Alabama and 46 others

Active not recruitingA Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Generalized Anxiety Disorder - VoyageNCT06741228·Gilbert, Arizona and 33 others

CompletedA Study of Duloxetine in Elderly Generalized Anxiety DisorderThe purpose of this study is to test the safety and efficacy of duloxetine versus placebo in elderly patients suffering from generalized anxiety disorder (GAD).NCT01118780·Orlando, Florida and 24 others

CompletedStudy of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety DisorderThe purpose of this study is to evaluate the safety and efficacy of 2.5 mg and 10 mg vortioxetine, once daily (QD), in adults with generalized anxiety disorder.NCT00731120·Birmingham, Alabama and 39 others

RecruitingA Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety DisorderThis is a global, phase 3, randomized, double-blind, parallel-group, 2-arm, placebo controlled, multicenter trial designed to compare the efficacy, safety and tolerability of a…NCT07767903·Redlands, California and 10 others

RecruitingTriage Survey for Psychiatry Research EligibilityTRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials.NCT05800925·Boston, Massachusetts and 5 others

CompletedGeneralized Anxiety Disorder Adjunct StudyThis study is being carried out to see if extended release quetiapine fumarate (Seroquel®XL) when added to standard selective serotonin reuptake inhibitor (SSRI) /…NCT00534599·Birmingham, Alabama and 52 others

TerminatedrTMS Pilot for AnxietyThe purpose of this study is to evaluate the safety and tolerability of 1 Hz parietal stimulation in anxiety.NCT05306977·Philadelphia, Pennsylvania

CompletedPregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).The primary objective of this study is to evaluate the efficacy of pregabalin as compared to placebo in the treatment of patients with general anxiety disorder (GAD).NCT00413010·Arcadia, California and 67 others

CompletedStudy to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.A 12-Month, Open-Label, Flexible-Dosage Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults with Generalized Anxiety Disorder.NCT00214994·Birmingham, Alabama and 92 others

CompletedLong Term Chamomile Therapy for AnxietyPrior research has shown that chamomile may be an effective, short-term anti-anxiety treatment.NCT01072344·Philadelphia, Pennsylvania

CompletedSafety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety DisorderThe purpose of this study is to demonstrate that quetiapine SR (SEROQUEL®) is efficacious and safe in the acute treatment of patients with Generalized Anxiety Disorder.NCT00329446·Birmingham, Alabama and 62 others

CompletedExperimental Medication For the Treatment of Generalized Anxiety DisorderThe purpose of this study is to determine whether an experimental anti-anxiety medication is effective in the treatment of Generalized Anxiety Disorder.NCT00097708·Birmingham, Alabama and 49 others

Page 1 of 2Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia